740 related articles for article (PubMed ID: 21075707)
1. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
Huang YC; Liu MF; Shen GH; Lin CF; Kao CC; Liu PY; Shi ZY
J Microbiol Immunol Infect; 2010 Oct; 43(5):401-6. PubMed ID: 21075707
[TBL] [Abstract][Full Text] [Related]
2. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
[TBL] [Abstract][Full Text] [Related]
4. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
Chu HS; Chang SC; Shen EP; Hu FR
PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
Özkarataş MH; Arslan N; Esen N; Özkütük AA
Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
[TBL] [Abstract][Full Text] [Related]
8. CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates.
Lee MR; Cheng A; Lee YC; Yang CY; Lai CC; Huang YT; Ho CC; Wang HC; Yu CJ; Hsueh PR
J Antimicrob Chemother; 2012 Jan; 67(1):222-5. PubMed ID: 21980068
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
He G; Wu L; Zheng Q; Jiang X
Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
[No Abstract] [Full Text] [Related]
10. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ
J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
Jeon K; Kwon OJ; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Koh WJ
Am J Respir Crit Care Med; 2009 Nov; 180(9):896-902. PubMed ID: 19661243
[TBL] [Abstract][Full Text] [Related]
12. Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.
Park J; Cho J; Lee CH; Han SK; Yim JJ
Clin Infect Dis; 2017 Feb; 64(3):301-308. PubMed ID: 28011609
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic resistance in
Jayasingam SD; Zin T; Ngeow YF
Int J Mycobacteriol; 2017; 6(4):387-390. PubMed ID: 29171453
[TBL] [Abstract][Full Text] [Related]
14. Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics.
Nie W; Duan H; Huang H; Lu Y; Bi D; Chu N
Int J Infect Dis; 2014 Aug; 25():170-4. PubMed ID: 24932856
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
Lee MC; Sun PL; Wu TL; Wang LH; Yang CH; Chung WH; Kuo AJ; Liu TP; Lu JJ; Chiu CH; Lai HC; Chen NY; Yang JH; Wu TS
J Antimicrob Chemother; 2017 Oct; 72(10):2782-2786. PubMed ID: 29091186
[TBL] [Abstract][Full Text] [Related]
16. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea.
Kim SY; Kim CK; Bae IK; Jeong SH; Yim JJ; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Kang YA
Diagn Microbiol Infect Dis; 2015 Feb; 81(2):107-11. PubMed ID: 25467784
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex.
Singh S; Bouzinbi N; Chaturvedi V; Godreuil S; Kremer L
Clin Microbiol Infect; 2014 Dec; 20(12):O1124-7. PubMed ID: 25185732
[TBL] [Abstract][Full Text] [Related]
18. Subspecies Distribution and Antimicrobial Susceptibility Testing of Mycobacterium abscessus Clinical Isolates in Madrid, Spain: a Retrospective Multicenter Study.
Ruedas-López A; Tato M; Broncano-Lavado A; Esteban J; Ruiz-Serrano MJ; Sánchez-Cueto M; Toro C; Domingo D; Cacho J; Barrado L; López-Roa P
Microbiol Spectr; 2023 Jun; 11(3):e0504122. PubMed ID: 37212700
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense.
Zhang Z; Lu J; Liu M; Wang Y; Zhao Y; Pang Y
Int J Antimicrob Agents; 2017 Mar; 49(3):383-386. PubMed ID: 28188830
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections.
Brown-Elliott BA; Mann LB; Hail D; Whitney C; Wallace RJ
Cornea; 2012 Aug; 31(8):900-6. PubMed ID: 22362004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
